Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Publications

Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy

Hor JY. et al, (2018), Journal of Neuroimmunology, 317, 100 - 102

Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence

Hor JY. et al, (2018), Multiple Sclerosis and Related Disorders, 19, 20 - 24

Inflammatory myopathy associated with myasthenia gravis with and without thymic pathology: Report of four cases and literature review

Santos E. et al, (2017), Autoimmunity Reviews, 16, 644 - 649

Chronic neuropathic pain severity is determined by lesion level in aquaporin 4-antibody-positive myelitis

Tackley G. et al, (2017), Journal of Neurology, Neurosurgery & Psychiatry, 88, 165 - 169

Epidemiology of myasthenia gravis in Northern Portugal: Frequency estimates and clinical epidemiological distribution of cases

Santos E. et al, (2016), Muscle & Nerve, 54, 413 - 421

Pain in patients with transverse myelitis and its relationship to aquaporin 4 antibody status

Kong Y. et al, (2016), Journal of the Neurological Sciences, 368, 84 - 88

Search for new phenomena in final states with an energetic jet and large missing transverse momentum inppcollisions ats=13 TeVusing the ATLAS detector

Aaboud M. et al, (2016), Physical Review D, 94

Pregnancy outcomes in aquaporin-4–positive neuromyelitis optica spectrum disorder

Nour MM. et al, (2016), Neurology, 86, 79 - 87

Congenital myasthenic syndrome due to mutation in CHRNE gene with clinical worsening and thymic hyperplasia attributed to association with autoimmune-myasthenia gravis

Santos E. et al, (2015), Neuromuscular Disorders, 25, 928 - 931

Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO

Kitley J. et al, (2015), Neurology - Neuroimmunology Neuroinflammation, 2, e121 - e121

Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease

Murchison A. et al, (2015), Journal of the Neurological Sciences, 355, 49 - 53

Update on biomarkers in neuromyelitis optica

Melamed E. et al, (2015), Neurology - Neuroimmunology Neuroinflammation, 2, e134 - e134

Use of Advanced Magnetic Resonance Imaging Techniques in Neuromyelitis Optica Spectrum Disorder

Kremer S. et al, (2015), JAMA Neurology, 72, 815 - 815

A 41-year-old woman with acute weakness and encephalopathy associated with MOG antibodies

Morris KA. et al, (2015), Neurology - Neuroimmunology Neuroinflammation, 2, e88 - e88

Clinical Features and Diagnostic Usefulness of Antibodies to Clustered Acetylcholine Receptors in the Diagnosis of Seronegative Myasthenia Gravis

Rodríguez Cruz PM. et al, (2015), JAMA Neurology, 72, 642 - 642

Demographic and clinical features of neuromyelitis optica: A review

Pandit L. et al, (2015), Multiple Sclerosis Journal, 21, 845 - 853

MOG cell-based assay detects non-MS patients with inflammatory neurologic disease

Waters P. et al, (2015), Neurology - Neuroimmunology Neuroinflammation, 2, e89 - e89

Myasthenia gravis: Association of British Neurologists’ management guidelines

Sussman J. et al, (2015), Practical Neurology, 15, 199 - 206

Whippits, nitrous oxide and the dangers of legal highs

Thompson AG. et al, (2015), Practical Neurology, 15, 207 - 209

Paediatric neuromyelitis optica: Clinical, MRI of the brain and prognostic features

Absoud M. et al, (2015), Journal of Neurology, Neurosurgery and Psychiatry, 86, 470 - 472

Load More

1
2
3
4
5

Include forthcoming?